Palbociclib in Real World Practice
-
- STATUS
- Recruiting
-
- participants needed
- 1500
-
- sponsor
- Pfizer
Updated on 18 January 2021
Pfizer CT.gov Call Center
Primary Contact
Contra Costa Oncology (2.2 mi away) Contact
+295 other locationbreast cancer
metastasis
advanced breast cancer
adenocarcinoma
palbociclib
breast adenocarcinoma
Summary
This Non-Interventional Study will describe and analyze the clinical use of palbociclib in routine clinical practice in the treatment of advanced breast cancer.
Details
| Treatment | Non-interventional |
|---|---|
| Clinical Study Identifier | NCT03280303 |
| Sponsor | Pfizer |
| Last Modified on | 18 January 2021 |
How clear was the trial content above?
Hard
Easy
Adding a note
Select a piece of text and start making personal notes.
Similar trials to consider
Loading...
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer